MENU

APUS

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Apimeds Pharmaceuticals US (APUS) Ownership - Who owns Apimeds Pharmaceuticals US?

Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Pharmaceuticals

Capitalization

11.12M

P/E Ratio

N/A

Total Cash

2.48M

Projected Growth

N/A

Total Debt

9.53M

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

0.16

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

APUS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for APUS

A.I. Advisor

published General Information

General Information

Industry PharmaceuticalsGeneric

Profile

Details